Freedom Investment Management, Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2018$261,000
-72.6%
7,935
-43.0%
0.02%
-66.7%
Q3 2018$954,000
+347.9%
13,927
+219.4%
0.06%
+361.5%
Q2 2018$213,000
-77.8%
4,360
-51.8%
0.01%
-73.5%
Q1 2018$960,000
+278.0%
9,039
+112.5%
0.05%
+276.9%
Q4 2017$254,000
+10.4%
4,254
-68.9%
0.01%
-23.5%
Q4 2015$230,00013,6620.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders